Brianti P, De Flammineis E, Mercuri SR. Review of HPV-related diseases and cancers. New Microbiol. 2017;40(2):80–5.

CAS  PubMed  Google Scholar 

Cobos C, et al. The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review. Int Rev Immunol. 2014;33(5):383–401.

Article  CAS  PubMed  Google Scholar 

Black E, Richmond R. Prevention of cervical cancer in Sub-Saharan Africa: the advantages and challenges of HPV vaccination. Vaccines (Basel). 2018;6(3):61.

Article  PubMed  Google Scholar 

World Health O. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2nd ed. Geneva: World Health Organization; 2021.

Google Scholar 

Crosbie EJ, et al. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889–99.

Article  PubMed  Google Scholar 

Carter JR, Ding Z, Rose BR. HPV infection and cervical disease: a review. Aust N Z J Obstet Gynaecol. 2011;51(2):103–8.

Article  PubMed  Google Scholar 

Arbyn M, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–203.

Article  PubMed  Google Scholar 

Rosalik K, Tarney C, Han J. Human papilloma virus vaccination. Viruses. 2021;13(6):1091.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mboumba Bouassa RS, et al. Natural and vaccine-induced B cell-derived systemic and mucosal humoral immunity to human papillomavirus. Expert Rev Anti Infect Ther. 2020;18(6):579–607.

Article  CAS  PubMed  Google Scholar 

Cheng L, Wang Y, Du J. Human papillomavirus vaccines: an updated review. Vaccines. 2020;8(3):391.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Oliveira CM, Fregnani J, Villa LL. HPV vaccine: updates and highlights. Acta Cytol. 2019;63(2):159–68.

Article  PubMed  Google Scholar 

Garland SM, et al. Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience. Clin Infect Dis. 2016;63(4):519–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malagón T, et al. Proportion of incident genital human papillomavirus detections not attributable to transmission and potentially attributable to latent infections: implications for cervical cancer screening. Clin Infect Dis. 2021;75:365–71.

Article  PubMed Central  Google Scholar 

Beachler DC, et al. An examination of HPV16 natural immunity in men who have sex with men (MSM) in the HPV in men (HIM) study. Cancer Epidemiol Biomark Prev. 2018;27(4):496–502.

Article  CAS  Google Scholar 

Mooij SH, et al. No evidence for a protective effect of naturally induced HPV antibodies on subsequent anogenital HPV infection in HIV-negative and HIV-infected MSM. J Infect. 2014;69(4):375–86.

Article  PubMed  Google Scholar 

Pamnani SJ, et al. Impact of serum antibodies to HPV serotypes 6, 11, 16, and 18 to risks of subsequent genital HPV infections in men: the HIM study. Cancer Res. 2016;76(20):6066–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pierce Campbell CM, et al. Human papillomavirus (HPV) L1 serum antibodies and the risk of subsequent oral HPV acquisition in men: the HIM study. J Infect Dis. 2016;214(1):45–8.

Article  PubMed  PubMed Central  Google Scholar 

Viscidi RP, et al. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis. 2003;188(12):1834–44.

Article  CAS  PubMed  Google Scholar 

Viscidi RP, et al. Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica. Cancer Epidemiol Biomark Prev. 2004;13(2):324–7.

Article  Google Scholar 

Viscidi RP, et al. Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women. Cancer Epidemiol Biomark Prev. 2005;14(1):283–8.

Article  CAS  Google Scholar 

Castellsague X, et al. Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA. J Infect Dis. 2014;210(4):517–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin SW, et al. HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays. PLoS ONE. 2013;8(1):e53067.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosillon D, et al. Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV-16/18 antibodies. Cancer Med. 2019;8(10):4938–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Safaeian M, et al. Risk of HPV-16/18 infections and associated cervical abnormalities in women seropositive for naturally acquired antibodies: pooled analysis based on control arms of two large clinical trials. J Infect Dis. 2018;218(1):84–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Safaeian M, et al. Epidemiological study of Anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections. J Natl Cancer Inst. 2010;102(21):1653–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Triglav T, et al. Effect of naturally acquired type-specific serum antibodies against human papillomavirus type 16 infection. J Clin Virol. 2017;90:64–9.

Article  CAS  PubMed  Google Scholar 

Wentzensen N, et al. A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study. J Infect Dis. 2011;204(1):94–102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilson L, et al. Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection. J Infect Dis. 2014;210(3):448–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beachler DC, et al. Natural acquired immunity against subsequent genital human papillomavirus infection: a systematic review and meta-analysis. J Infect Dis. 2016;213(9):1444–54.

Article  CAS  PubMed  Google Scholar 

Looker KJ, et al. Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status. J Int AIDS Soc. 2018;21(6):e25110.

Article  PubMed  PubMed Central  Google Scholar 

Denslow SA, et al. Incidence and progression of cervical lesions in women with HIV: a systematic global review. Int J STD AIDS. 2014;25(3):163–77.

Article  PubMed  Google Scholar 

Huchko MJ, et al. The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countries. J Int AIDS Soc. 2015;18(Suppl 5):20282–20282.

Article  PubMed  PubMed Central  Google Scholar 

DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28(2):105–14.

Article  PubMed  Google Scholar 

Borenstein M, Higgins JPT. Meta-analysis and subgroups. Prev Sci. 2013;14(2):134–43.

Article  PubMed  Google Scholar 

Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol. 2005;32(Suppl 1):S16-24.

Article  PubMed  Google Scholar 

Gautam A, et al. Human papillomavirus genome based detection and typing: a holistic molecular approach. Curr Mol Med. 2019;19:237–46.

Article  CAS  PubMed  Google Scholar 

Wells, G. A., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., Tugwell, P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.

Egger M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

CRAN. meta: general package for meta-Analysis. The comprehensive R archive network. https://cran.r-project.org/web/packages/meta/meta.pdf.

Kelly H, et al. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. Lancet HIV. 2018;5(1):e45–58.